Disease/Infection News

RSS
Reduced butyrate production in the microbiome of type 2 diabetics

Reduced butyrate production in the microbiome of type 2 diabetics

Post-COVID-19 CT scans show lung abnormalities persist two years later

Post-COVID-19 CT scans show lung abnormalities persist two years later

COVID-19 is associated with higher diabetes and hypertension risk

COVID-19 is associated with higher diabetes and hypertension risk

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Nirmatrelvir-ritonavir therapy effective against Omicron BA.4/BA.5

Delayed presentation of MIS-C following COVID-19

Delayed presentation of MIS-C following COVID-19

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

New insights into the driving factors of COVID-19 dynamics in England

New insights into the driving factors of COVID-19 dynamics in England

Comparative study on retinoic acid-inducible gene-I of humans and bats

Comparative study on retinoic acid-inducible gene-I of humans and bats

Jamaican fruit bat's response to SARS-CoV-2 adapted to human

Jamaican fruit bat's response to SARS-CoV-2 adapted to human

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Study: Organ damage persists in 59% of COVID patients a year after initial symptoms

Study: Organ damage persists in 59% of COVID patients a year after initial symptoms

What is the tolerability profile and rate of recurrent CDI after administrating microbiome therapeutic SER-109 post-antibiotic treatment?

What is the tolerability profile and rate of recurrent CDI after administrating microbiome therapeutic SER-109 post-antibiotic treatment?

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

Isolation of Burkholderia thailandensis from the environment

Isolation of Burkholderia thailandensis from the environment

Study finds RSV responsible for most infant hospitalizations in the European Union

Study finds RSV responsible for most infant hospitalizations in the European Union

Aerosol experts provide an account of the rejection of aerosol science by the WHO

Aerosol experts provide an account of the rejection of aerosol science by the WHO

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.